Over our 25 years as rheumatologists, care has advanced greatly. We each completed our rheumatology training in the late 1990s when both infliximab and etanercept first arrived on the U.S. market, ushering in the era of biologics in rheumatology. Since this time, our greater understanding of the immunologic basis of many rheumatic diseases has translated into a growing list of targeted therapies.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Andrew L. Concoff
Precision Medicine on a Population Level: Can digital health technology improve access to rheumatologic care?
Over our 25 years as rheumatologists, care has advanced greatly. We each completed our rheumatology training in the late 1990s when both infliximab and etanercept first arrived on the U.S. market, ushering in the era of biologics in rheumatology. Since this time, our greater understanding of the immunologic basis of many rheumatic diseases has translated into a growing list of targeted therapies.
Knee Osteoarthritis Treatment Costs in the Medicare Patient Population
Knee osteoarthritis (OA) places a substantial health burden on patients, and also places an economic burden on the healthcare system. Knee OA contributes to more than $27 billion in annual healthcare costs, with expenditures related to total knee arthroplasty exceeding $11 billion annually.1-3 In addition to total knee arthroplasty, several nonsurgical therapies are frequently considered for the treatment of patients with knee OA.
Claims surveillance, patient surveys 'critical' to track COVID-19 in rheumatology patients
Combining broad-based surveillance strategies with frequent patient surveys can help rheumatologists keep tabs on their patients in the setting of COVID-19, according to findings presented during a webinar hosted by United Rheumatology. “We still do not understand the relationship between our patients, COVID-19, the medications they are using and the risks,” Andrew L.
COVID-19 threatens rheumatology practices amid plunging patient volume, revenue
Rheumatology practices across the United States have reported significant decreases in patient visits and revenue as a result of COVID-19, losses which have contributed to staff furloughs and endangered the sustainability of some practices, according to survey data presented during a webinar hosted by United Rheumatology. “Since March 15, we have all lived a life of adaptation,” Max I.
Rheumatologists sound alarm over 90% Medicare reimbursement cut for ultrasounds
Those who wish to submit a comment can do so at this link: https://www.regulations.gov/document?D=CMS-2018-0076-0621. “Comment should be submitted to CMS urging them to postpone further cuts to the code pending further comments from stakeholders and submission of evidence supporting a proper revaluation of the 76881 code,” Laster said.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Andrew L.
Contact Andrew L., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack